Research Paper Volume 14, Issue 23 pp 9715—9729
A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy
Figure 8. GSEA of DEGs between high-risk and low-risk levels in MIBC patients who received GC regimens. (A) Top 10 GSEA terms of the DEGs; (B) GSEA plot of the term “GOBP_ADAPTIVE_IMMUNE_RESPONSE”; (C) GSEA plot of the term “GOCC_IMMUNOGLOBULIN_COMPLEX”; (D) GSEA plot of term “GOCC_T_CELL_RECEPTOR_COMPLEX”.